Citations for
1H19, WT2
Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor.
Scott RH, Douglas J, Baskcomb L, Huxter N, Barker K, Hanks S, Craft A, Gerrard M, Kohler JA, Levitt GA, Picton S, Pizer B, Ronghe MD, Williams D; Factors Associated with Childhood Tumours (FACT) Collaboration, Cook JA, Pujol P, Maher ER, Birch JM, Stiller CA, Pritchard-Jones K, Rahman N.
Nat Genet 40(11):1329-34. Epub 2008 Oct 5. 2008
2WT2, ZNF195
Multipoint analysis of human chromosome 11p15/mouse distal chromosome 7: inclusion of H19/IGF2 in the minimal WT2 region, gene specificity of H19 silencing in Wilms' tumorigenesis and methylation hyper-dependence of H19 imprinting.
Dao D, Walsh CP, Yuan L, Gorelov D, Feng L, Hensle T, Nisen P, Yamashiro DJ, Bestor TH, Tycko B.
Hum Mol Genet 8(7):1337-52. 1999
3TSG11D, WT2
Loss of heterozygosity at chromosome 11p15 in Wilms tumors : identification of two independent region.
Karnik P, et al.
Oncogene 17 : 237-240. 1998
4IGF2, H19, WT2
Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis.
Okamoto K, et al.
Proc Natl Acad Sci U S A 94 : 5367-5371. 1997
5BWS, WT2
Novel transcribed sequences within the BWS/WT2 region in 11p15.5 : tissue-specific expression correlates with cancer type.
Crider-Miller SJ, Reid LH, Higgins MJ, Nowak NJ, Shows TB, Futreal PA, Weissman BE.
Genomics 46(3):355-63. 1997
6WT2, ST5
A common region of loss of heterozygosity in Wilms'tumor and embryonal rhabdomyosarcoma distal to the D11S988 locus on chromosome 11p15.5.
Besnard-Guˇrin C, et al.
Hum Genet 97 : 163-170. 1996
7ST5, WT2
Localization of a tumor suppressor gene in 11p15.5 using the G401 Wilms'tumor assay.
Reid LH, et al.
Hum Mol Genet 5 : 239-247. 1996
8H19, ST5, WT2
Epigenetic lesions at the H19 locus in Wilms'tumour patients.
Moulton T, et al.
Nat Genet 7 : 440-447. 1994
9H19, IGF2, WT2
Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms'tumour.
Steenman MJC, et al.
Nat Genet 7 : 433-439. 1994
10WT1, WT2
Molecular genetic analysis of chromosome 11p in familial Wilms tumor.
Baird PN, et al.
Br J Cancer 69 : 1072-1077. 1994
11WT1, WT2
The genetics of Wilms' tumor-A case of disrupted development.
Hastie ND.
Annu Rev Genet 28 : 523-558. 1994
12WT1, WT2, TSG11A, ST5
Deletion of WT1 and WIT1 genes and loss of heterozygosity on chromosome 11p in Wilms tumors in Japan.
Kaneko Y, et al.
Jpn J Cancer Res 84 : 616-624. 1993
13WT1, WT2, TSG11A, ST5
Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination.
Coppes MJ, et al.
Genes Chromosomes Cancer 5 : 326-334. 1992
14WT1, WT2
Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11.
Wadey RB, et al.
Oncogene 5 : 901-907. 1990
15BWS, WT2
Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5.
Koufos A, et al.
Am J Hum Genet 44 : 711-719. 1989
16WT1, WT2
Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilm's tumours.
Mannens M, et al.
Hum Genet 81 : 41-48. 1988